WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca’s fixed-dose triple-combination therapy BREZTRI Aerosphere® (budesonide/glycopyrrolate/formoterol fumarate or BGF ...
The approval is expected to offer more affordable treatment options and potentially reduce asthma-related complications nationwide. The FDA has authorized the first generic version of fluticasone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results